Looking to the Future with HIF-PHIs

CE / CME

Lowering the Burden of Anemia in CKD: Looking to the Future with HIF-PHIs

Physicians: maximum of 1.00 AMA PRA Category 1 Credit™ 

Registered Nurses: 1.00 Nursing contact hour

US Physicians: maximum of 1.00 Medical Knowledge MOC point

Released: December 20, 2022

Expiration: December 19, 2023

Pretest

Progress
1 2
Course Completed
1.

How confident are you in management of anemia in CKD

2.

Which of the following contributes to the development of anemia in CKD? 

3.

Which of the following is true regarding health-related quality of life (HRQOL) in patients with CKD and anemia who are treated with ESAs? 

4.

Which of the following is a consideration when selecting a therapy of anemia in CKD? 

5.

The mechanism of action of Hypoxia-Inducible Factor (HIF)-Proline Hydroxylase Inhibitor (PHI) agents is based on which of the following?